Sanofi is a leading global healthcare and healthcare company that studies, develops and promotes innovative treatment programs based on patient needs. Sanofi has five major global divisions: Diabetes and cardiovascular disease, general medicine and emerging markets, Sanofi Kenyon, Sanofi Pasteur and Merial. 2015, Sanofi net sales of 37.057 billion euros.

Sanofi has always been adhering to the promise of China. In 1982, Sanofi opened an office in China, among the first multinational pharmaceutical companies to enter China. Sanofi currently has more than 9,000 employees in China and one of the fastest growing pharmaceutical companies in China. Sanofi is headquartered in Shanghai and has 11 regional offices in Beijing, Tianjin, Shenyang, Jinan, Shanghai, Hangzhou, Nanjing, Wuhan, Chengdu, Guangzhou and Urumqi.

Sales Markets

East Asia (e.g. China, Japan, Korea); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Primary business activity

Manufacturer/Innovator

Meet us at

CPhI & PMEC China 2021

SNIEC, Shanghai, China

16 - 18 December 2021

Book a meeting
View Our Exhibitor Profile

Contact information

Address

Telephone

Website

View All Contact Info

Top Products

21 Kim Wei He

Sanofi(China)Investment Co., Ltd. Shanghai

Request Info

Acebutolol hydrochloride

Sanofi(China)Investment Co., Ltd. Shanghai

Request Info

Acexamic acid

Sanofi(China)Investment Co., Ltd. Shanghai

Request Info

Alimemazine tartrate

Sanofi(China)Investment Co., Ltd. Shanghai

Request Info

Categories affiliated with Sanofi(China)Investment Co., Ltd. Shanghai